Isosporiasis in HIV/AIDS Patients in Edo State, Nigeria

Article Sidebar

PDF
Published: Sep 30, 2009
DOI: https://doi.org/10.21315/
Keywords:
Isospora belli, HIV, medical sciences, CD4 + T lymphocytes,

Main Article Content

Akinbo Frederick Olusegun
Department of Pathology, University of Benin Teaching Hospital, PMB 1111, Benin City, Edo State, Nigeria
Christopher Ehis Okaka
Department of Animal and Environmental Biology, University of Benin, PMB 1154, Benin City, Edo State, Nigeria
Ricardo Luiz Dantas Machad
Center for Microorganism Investigation, Faculty of Medicine, Central Laboratory, Sao Paulo, Brazil

Abstract

Background: The role of opportunistic infections in accelerating disease progression in HIVpositive individuals, leading to quick death, is still receiving serious attention. The objective of this study was to determine the prevalence of Isospora belli infections in HIV-positive patients in Edo State, Nigeria between August 2007 and March 2008. Methods: A total of 268 samples from HIV-positive patients and 20 samples from HIV-negative patients were processed using the modified Ziehl-Neelsen staining technique to microscopically identify the presence of I. belli oocysts. Results: The overall prevalence of the coccidian was 3.1%. Gender and age had no correlation with the prevalence of the parasite (P > 0.05). There was a significant relationship between isosporiasis
and CD4+ T cell counts in HIV-positive patients (OR=11.388, 95% CI= 2.797–46.371, P=0.0004). Conclusions: Routine investigation of I. belli in HIV-positive subjects is advocated in tertiary health institutions

Article Details

How to Cite
1.
Akinbo Frederick Olusegun, Christopher Ehis Okaka, Ricardo Luiz Dantas Machad. Isosporiasis in HIV/AIDS Patients in Edo State, Nigeria. Malays J Med Sci [Internet]. 2009 Sep. 30 [cited 2026 Oct. 22];16(3):41-4. Available from: https://ejournal.usm.my/mjms/article/view/mjms_vol16-no3-2009_7
Issue
Vol. 16 No. 3 (2009)
Section
Brief Communication
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.